(Q46113181)

English

Development and characterization of solid oral dosage form incorporating candesartan nanoparticles

scientific article published in January 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

Development and characterization of solid oral dosage form incorporating candesartan nanoparticles (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

0 references

author name string

Vijaykumar Nekkanti

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

Raviraj Pillai

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

Vobalaboina Venkateshwarlu

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

T Harisudhan

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

Pharmaceutical Development and Technology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

14

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

290-298

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

Nanosizing: a formulation approach for poorly-water-soluble compounds

1 reference

https://api.crossref.org/works/10.1080%2F10837450802585278

21 January 2018

Nanosizing--oral formulation development and biopharmaceutical evaluation

1 reference

https://api.crossref.org/works/10.1080%2F10837450802585278

21 January 2018

Drug Nano‐ and Microparticles Processed into Solid Dosage Forms: Physical Properties

1 reference

https://api.crossref.org/works/10.1080%2F10837450802585278

21 January 2018

Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine

1 reference

https://api.crossref.org/works/10.1080%2F10837450802585278

21 January 2018

Critical freezing rate in freeze drying nanocrystal dispersions.

1 reference

https://api.crossref.org/works/10.1080%2F10837450802585278

21 January 2018

Identifiers

10.1080/10837450802585278

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19235553

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46113181&oldid=2093248931"